Follow us on
Log In  |  Sign-Up
Mail
Print

Wall St flat ahead of Fed policy statement

By Rodrigo Campos
Source REUTERS
 | 2010-03-16 20:20:00
Wall St flat ahead of Fed policy statement

U.S. stocks were little changed in early trading on Tuesday ahead of a statement from the Federal Reserve on monetary policy and the state of the economy.

The Fed is seen holding interest rates near zero, and analysts widely expect the bank's statement to say again that high unemployment and low inflation warrant holding borrowing costs "exceptionally low" for "an extended period."

That stance has helped stocks rally as the flow of cheap money encourages investors to look for returns in riskier assets.

The U.S. dollar dipped on the expectation of low interest rates, lifting crude and gold prices and giving a boost to materials shares.

The S&P materials sector rose 1 percent with miner Cliffs Natural Resources Inc up 4.7 percent to $66.13.

"We're seeing hesitation before the Fed announcement this afternoon," said Dan Cook, senior market analyst at IG Markets in Chicago.

He said he doesn't expect the Fed to extend its buying of mortgage-backed securities, which has been winding down and is expected to end this month, but "the market will be hesitant" if there are any unexpected news on the subject.

The Dow Jones industrial average gained 0.38 point, flat in percentage terms, to 10,642.53. The Standard & Poor's 500 Index rose 1.91 points, or 0.17 percent, to 1,152.42. The Nasdaq Composite Index added 1.90 points, or 0.08 percent, to 2,364.11.

Healthcare sector stocks fell after Goldman Sachs said in a research note it sees a more than 50 percent chance healthcare overhaul legislation will pass Congress and adjusted its ratings on several companies.

Goldman removed Teva Pharmaceutical Industries and UnitedHealth Group from its "Conviction Buy" list but kept its rating at "buy." Teva shares fell 0.8 percent to $60.47 and UnitedHealth dropped 0.6 percent to $32.35.

The Morgan Stanley healthcare payor index fell 0.3 percent.

Discussions of healthcare reform have made investors cautious as they scramble to gauge the implications of legislation on profits for the sector's companies.

(Editing by Padraic Cassidy)

(For more business news on Reuters Money visit http://www.reutersmoney.in)



blog comments powered by Disqus
most popular on facebook
talking point on sify finance